Investing.com - Finch Therapeutics Group (NASDAQ:FNCH) reported on Thursday third quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
Finch Therapeutics Group announced earnings per share of $-0.85 on revenue of $138K. Analysts polled by Investing.com anticipated EPS of $-0.40 on revenue of $750K.
Finch Therapeutics Group shares are down 4.96% from the beginning of the year, still down 94.02% from its 52 week high of $17.39 set on December 1, 2021.
Finch Therapeutics Group shares gained 1.46% in intra-day trade following the report.
Finch Therapeutics Group follows other major Healthcare sector earnings this month
Finch Therapeutics Group's report follows an earnings beat by UnitedHealth on October 14, who reported EPS of $5.79 on revenue of $80.89B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on October 18 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar